← Open Payments lookup

NELLY ZUNIGA: Open Payments

NPI 1194405803 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,215 in 40 payments from 9 companies in 2025. Trend: 2023 $423 · 2024 $1,196 · 2025 $1,215

Food & beverage: $1,215
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$318
Teva Pharmaceuticals USA, Inc.6$302
ABBVIE INC.11$222
Vanda Pharmaceuticals Inc.1$125
Otsuka America Pharmaceutical, Inc.4$98
Lundbeck LLC4$71
Alkermes, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.1$24
Indivior Inc.1$15

Products named: CAPLYTA, UZEDY, VRAYLAR, REXULTI, FANAPT, AUSTEDO XR, LYBALVI, TRINTELLIX.

Industry payments across TX — which companies pay providers there.